Jonas Båtelson

Co-Founder & Chief Executive Officer CuraCell Holding AB

Jonas is an entrepreneur and investor in biopharma and digital health tech and the CEO of the holding company Takura AB. Jonas has 15 years of experience from management consulting (Partner at Applied Value LLC) with extensive experience from innovation, transformation and commercial roll-outs in both Europe and the US across various segments in healthcare and life sciences. He also serves as an active board member for various life science companies (e.g. Cellcolabs AB, Medituner AB and ImagineCare AB).

Jonas founded CuraCell in 2022 by merging the research teams and their assets on which CuraCell’s core technology stems from. Born in 1977, MSc. in Industrial Engineering from Chalmers University and BSc in Financial Economics from Gothenburg University, Sweden.

Seminars

Thursday 19th November 2026
Q&A & Panel Discussion: Evaluating TIL Programs Through an Investor Lens to Drive Sustainable Growth
2:15 pm
  • Examining how TIL leaders are balancing clinical efficacy, manufacturing complexity, and capital efficiency as investors become increasingly selective following capital-intensive cell therapy experiences
  • Discussing the strategic decisions CEOs face when prioritizing indications, advancing next-generation platforms, pursuing partnerships, and managing development risk in a constrained funding environment
  • Identifying the clinical, operational, and commercial milestones that most effectively rebuild investor confidence, support sustainable financing, and create long-term enterprise value
Jonas Batelson - - speaker for 8th TIL Therapies Summit